CClinicalTrials.gg
TerminatedNCT04164043Updated Mar 22, 2023

Efficacy of a Recreation Therapy Wellness Recovery Program for Individuals With Parkinson's Disease

An interventional study of Wellness Recovery Program in Parkinson's Disease, sponsored by Wake Forest University Health Sciences. Terminated at 1 site in United States. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2023-03-22.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Supportive care

Why this study was terminated
Decision made on 8/16/2021 due to difficult enrollment because of limited access for enrollees during the pandemic and changes in staff

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Mar 2018, registered Nov 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
45 Years and older
Sex
All
01

Study summary

The Recreation Therapy Wellness Recovery Program conducts group classes which provide repetitive training of foundational skills designed specifically for those with Parkinson's Disease. The course will encourage bigger and faster movements (adapted from the Parkinson Wellness Recovery, PWR!Moves ® program) and education on optimal function.

Read the detailed description

The purpose of this project is to evaluate a currently active community-based Recreational Therapy (RT) Wellness Recovery Program (WRP) for individuals with Parkinson's disease (PD) to determine the efficacy of the treatment intervention. Since PD is a progressive, degenerative neurological disease, it is critical that individuals with this diagnosis remain as active as possible to slow down the progression of the disease, improve balance and strength, and increase health-related quality of life. The overall goal of this project is to determine the efficacy of a neuroplasticity physical activity program in terms of improving balance, improving health-related quality of life, reducing stress, and increasing satisfaction in exercise including social connectedness of group exercise. There is evidence that the neuroplasticity model may be a more effective type of intervention than traditional exercise programs in improving symptoms of PD. The neuroplasticity approach requires repetition of complex tasks that are high intensity and present a novel challenge. This type of intervention has been shown to improve motor and cognitive behaviors which are critical areas of decline for those with PD. The WRP program uses a comprehensive neuroplasticity-principled program that integrates exercise and wellness. The PI, Julie Bradwell, LRT/CTRS is a Certified Instructor for Parkinson Wellness Recovery Power Moves. The RT Wellness Recovery program at Wake Forest Baptist Health is modeled on the Parkinson Wellness Recovery Power Moves. Components within the program include the Parkinson Power Moves and the exercise 4 Brain Change. This study will be a 14-week study with the first two weeks of collecting baseline data and immediately following with a 12-week intervention program to increase balance, health-related quality of life, and satisfaction in exercise in individuals with PD as well as reduce stress. Most research on RT interventions for this population are in traditional settings (inpatient or rehabilitation settings). When discharged from these settings, many individuals become less active, have few social interactions and lose the benefits of exercise and physical therapy they gained while in these programs once they are home. The WRP community-based program at Wake Forest Baptist Health has the potential to prevent secondary complications as well as slow down the progression of the disease for participants. If the outcomes of this project suggest this type of intervention will improve the functional skills, quality of life, and/or satisfaction in exercise for individuals with PD and reduce stress, it will provide the RT discipline with evidenced based practice intervention for this population

02

Conditions studied

  • Parkinson's Disease

Browse trials for

Keywords

  • Recreation Therapy
  • Community Based
  • Movement Disorder
  • Wellness Recovery Program
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,081 are open to participants now.

This study's enrollment of 3 is below the median of 40 across 3,293 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Potential subjects in this study will have a diagnosis of Parkinson's disease.
  • Potential subjects in this study are able to tolerate a 60-minute exercise program; participants complete the Parkinson Power Moves Class Application which requires a release form and a physician's signature that identifies any limitations or precautions to be taken in the program.

Exclusion criteria

Exclusion Criteria:

  • Individuals who do not have a diagnosis of Parkinson's disease or those with PD who are not medically cleared to participate in the program will be excluded.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    Recreational Therapy Wellness Recovery Program Group

    All participants will enter a baseline data collection period for two weeks. They will then participate in a 12-week community-based Recreational Therapy (RT) Wellness Recovery Program (WRP) for individuals with Parkinson's disease (WRP).

    Behavioral: Wellness Recovery Program

Interventions

  • BehavioralWellness Recovery Program

    12-week community-based recreation therapy

    Also known as: WRP

06

What researchers measure

Primary outcomes

  1. Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  2. Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  3. Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Time frame: Week 4 post baseline period

  4. Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Time frame: Week 8 post baseline period

  5. Sit to Stand Test

    Measures functional muscle strength in the lower limbs. This test is reported in seconds.

    Time frame: Week 12 post baseline period

  6. Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  7. Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  8. Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Time frame: Week 4 post baseline period

  9. Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Time frame: Week 8 post baseline period

  10. Timed Floor Transfer Test

    Measures vestibular balance and functional mobility to determine risk of falling. This test is reported in seconds.

    Time frame: Week 12 post baseline period

  11. Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  12. Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  13. Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Time frame: Week 4 post baseline period

  14. Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Time frame: Week 8 post baseline period

  15. Timed Up and Go (TUG) test

    Test involves a series of transitional movements including sit to stand, walking, turning and sit to stand. The test is reported in seconds.

    Time frame: Week 12 post baseline period

  16. The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  17. The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  18. The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Time frame: Week 4 post baseline period

  19. The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Time frame: Week 8 post baseline period

  20. The Blue Foam (stand) with Trek Poles Test

    Test involves lateral moves and front and back moves with or without assistance. measures level of assistance needed: supervision or modified assistance.

    Time frame: Week 12 post baseline period

  21. Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  22. Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  23. Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Time frame: Week 4 post baseline period

  24. Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Time frame: Week 8 post baseline period

  25. Parkinson's Disease Questionnaire Short Form (PDQ8)

    This is a spcific health related quality of life instrument created for individuals with Parkinson's Disease. Likert scale (0 - 4), higher the score the greater the functioning. Overall score ranges from 0 -32. Higher scores indicate greater impact of the disease

    Time frame: Week 12 post baseline period

  26. Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  27. Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  28. Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Time frame: Week 4 post baseline period

  29. Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Time frame: Week 8 post baseline period

  30. Psychological Need Satisfaction in Exercise Scale (PNSES)

    Total range 1-6. Lower scores denotes worse outcome.

    Time frame: Week 12 post baseline period

  31. Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Time frame: Baseline Measure 1 performed at day 1 after signing consent

  32. Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Time frame: Baseline Measure 2 performed at day 2 after signing consent

  33. Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Time frame: Week 4 post baseline period

  34. Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Time frame: Week 8 post baseline period

  35. Perceived Stress Scale (PSS-10)

    Total range 0-4. Lower scores denotes worse/better outcome.

    Time frame: Week 12 post baseline period

  36. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 3 after signing consent

  37. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 4 after signing consent

  38. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 5 after signing consent

  39. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 6 after signing consent

  40. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 7 after signing consent

  41. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 8 after signing consent

  42. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 9 after signing consent

  43. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 10 after signing consent

  44. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 11 after signing consent

  45. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 12 after signing consent

  46. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 13 after signing consent

  47. Pain Rating Scale

    10 point rating scale, low score indicates less pain.

    Time frame: completed week 14 after signing consent

07

Study locations

1 site
  • Wake Forest University Health Sciences
    Winston-Salem, North Carolina 27157, United States
08

References and documents

Study documents

  • Informed consent form · Sep 15, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04164043
Lead sponsor
Wake Forest University Health Sciences
Responsible party
Sponsor
First posted
Nov 15, 2019
Start date
Mar 6, 2018
Primary completion
Feb 5, 2019
Completion
Feb 5, 2019
Last update
Mar 22, 2023

Study contacts

Peggy Cromer, LRT
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion